Problem being addressed[edit | edit source]

Twelve percent of newborns need to receive immediate treatment for severe jaundice. This problem can be solved through the use of phototherapy treatment, but in low-income settings existing phototherapy options are often ineffective, costly, difficult to maintain, and improperly used.

Detailed description of the solution[edit | edit source]

Comet is a low-cost, high-performance, and compact jaundice treatment device intended to be used in rural clinics or as a backup for urban hospitals. This device is a cheaper, smaller and more energy-efficient device than Brilliance, another phototherapy device developed by the same design team. Comet utilizes high intensity light-emitting diodes (LEDs) which provide the intense blue light to treat jaundice. Comet has a lifespan of 3-5 years, requires minimal maintenance, and is designed to retail at less than $150.

Designed by[edit | edit source]

  • Designed by:Design Revolution: Design for the Other Ninety Percent
  • Manufacturer (if different):
  • Manufacturer location: Palo Alto, CA, USA

When and where it was tested/implemented[edit | edit source]

India and Nepal

Funding Source[edit | edit source]

Finalist in Saving Lives at Birth Competition One Heart World-Wide

References[edit | edit source]

Peer-reviewed publication[edit | edit source]

Other internally generated reports[edit | edit source]

Hong, M. (2013, October 07). [Web log post]. Retrieved from

Externally generated reports[edit | edit source]

Cheaper, greener blue light: A better phototherapy device for jaundice treatment. Retrieved from

Comet: Effective, compact, and low-cost phototherapy to treat newborn jaundice. (August 8, 2012). Retrieved from

IP and copyright[edit | edit source]

Approval by regulatory bodies or standards boards[edit | edit source]

Discussion[View | Edit]

Cookies help us deliver our services. By using our services, you agree to our use of cookies.